Jon covers artificial intelligence. He previously led CNET's home energy and utilities category, with a focus on energy-saving advice, thermostats, and heating and cooling. Jon has more than a decade ...

More than two dozen contributors to the manual criticized the deletion of a chapter on climate science by the Federal Judicial Center. By Karen Zraick More than two dozen contributors to a widely used ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...

Good morning. Welcome to the Jefferies London Healthcare Conference. My name is Dennis Ding, biotech analyst here at Jefferies. I have the wonderful pleasure of having Recursion Pharmaceuticals up ...

We’re one of the top-ranked engineering schools in the country because of our internationally renowned faculty and motivated students. We keep classes small so you can get the most out of your program ...

A poll from the journal Nature found that 75% of researchers in the U.S. are considering leaving the country. That includes a man who’s been dubbed the "Mozart of Math." Stephanie Sy examines what’s ...

The Seattle-based Fund for Science and Technology (FFST) announced an inaugural set of grants and its plan to fund at least $500 million over the next four years to support transformational science ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. For its second quarter, Recursion earned $19.2 million in ...

An analysis by the American Association for the Advancement of Science shows the impact of the administration’s budget plan on the kind of studies that produce the most breakthroughs. By William J.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...